Form 8-K - Current report:
SEC Accession No. 0001628280-22-010197
Filing Date
2022-04-26
Accepted
2022-04-26 09:12:21
Documents
22
Period of Report
2022-04-26
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bvs-20220426.htm   iXBRL 8-K 60129
2 EX-99.1 exhibit991-april2022erpres.htm EX-99.1 45286
3 EX-99.2 exhibit992-april2022acqrel.htm EX-99.2 14371
4 EX-99.3 exhibit993-april2022busine.htm EX-99.3 215917
5 EX-99.4 exhibit994-april2022misoni.htm EX-99.4 446969
6 EX-99.5 exhibit995april2022proforma.htm EX-99.5 212731
10 bioventuslogo.jpg GRAPHIC 15224
11 bioventuslogob.jpg GRAPHIC 15224
12 portfolioii.jpg GRAPHIC 151095
13 segmentii.jpg GRAPHIC 143819
14 segmentshared.jpg GRAPHIC 136481
  Complete submission text file 0001628280-22-010197.txt   1891897

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bvs-20220426.xsd EX-101.SCH 1902
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bvs-20220426_lab.xml EX-101.LAB 25848
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bvs-20220426_pre.xml EX-101.PRE 13582
16 EXTRACTED XBRL INSTANCE DOCUMENT bvs-20220426_htm.xml XML 12327
Mailing Address 4721 EMPEROR BOULEVARD, SUITE 100 DURHAM NC 27703
Business Address 4721 EMPEROR BOULEVARD, SUITE 100 DURHAM NC 27703 (919) 474-6700
Bioventus Inc. (Filer) CIK: 0001665988 (see all company filings)

EIN.: 810980861 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37844 | Film No.: 22851982
SIC: 3841 Surgical & Medical Instruments & Apparatus